Where is Syncona Partners LLP headquartered?

Syncona Partners LLP is located in London, england.

Who invested in Syncona Partners LLP?

Syncona Partners LLP has 13 investors including Geekdom Fund And Geekdom Fund.

How much funding has Syncona Partners LLP raised to date?

Syncona Partners LLP has raised ____.

When was the last funding round for Syncona Partners LLP?

Syncona Partners LLP closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

synconaltd.com

Syncona Partners LLP

Syncona Partners LLP is a healthcare company focused on investing in and building global leaders in life science.

Business Model: B2B

Revenue: $33.3M

Employees: 1,001-5,000

Rankings

Industries / Tags:

Banking, Financial Services and Insurance

Detailed Syncona Partners LLP Information

General Information

Geographic Data

Address: 8 Bloomsbury Street

City: London

State: england

Zip: WC1B 3SR

Country: GB

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Social

Twitter

Crunchbase

Metrics

4,170,704Website Global Rank

2,616Website Monthly Traffic

Twitter Followers

Description

Syncona is a leading healthcare company focused on investing in and building global leaders in life science. Their vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders. They seek to partner with the best, brightest and most ambitious minds in science to build globally competitive businesses. They take a long-term view, underpinned by a deep pool of capital, and are established leaders in the development of genetic medicine, particularly gene and cell therapy. They focus on delivering dramatic efficacy for patients in areas of high unmet need. Syncona is aligned with two of the premium charitable funders in UK science, The Wellcome Trust, original founder of Syncona, and Cancer Research UK, both of which are significant shareholders in their business. They make a donation of 0.3% of Net Asset Value to a range of charities each year.

Contact Phone:

Contact Email:

IPO Details